Akihiko Osaki
- Cancer Research top 5%
- Breast Cancer Treatment Studies 28
- Oncology top 5%
- HER2/EGFR in Cancer Research 24
- Cancer Treatment and Pharmacology 23
-
- Medical Imaging Techniques and Applications 8
- Hepatology top 10%
- Liver Disease and Transplantation 10
-
- Estrogen and related hormone effects 13
-
- Breast Lesions and Carcinomas 13
-
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Tetsuya TogeTakashi ShigekawaToshiaki SaekiShigeto UedaIchiei KujiKazuhiro IkedaSatoshi InoueKuniko Horie‐Inoue
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Akihiko Osaki
110 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 528
- Oncology 747
- Radiology, Nuclear Medicine and Imaging 325
- Hepatology 87
- Pulmonary and Respiratory Medicine 283
Countries citing papers authored by Akihiko Osaki
This map shows the geographic impact of Akihiko Osaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Osaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Osaki more than expected).
Fields of papers citing papers by Akihiko Osaki
This network shows the impact of papers produced by Akihiko Osaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Osaki. The network helps show where Akihiko Osaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akihiko Osaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 8 | |
| 7 | 2017 | 67 | |
| 8 | 2016 | 13 | |
| 9 | 2015 | 9 | |
| 10 | Supporting Science Communication in a Museum using Ubiquitous Learning Logs. | 2014 | 1 |
| 11 | 2014 | 19 | |
| 12 | [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report]. | 2013 | 3 |
| 13 | 2012 | 15 | |
| 14 | 2010 | 9 | |
| 15 | 2006 | 11 | |
| 16 | 2005 | 12 | |
| 17 | 2005 | 34 | |
| 18 | 2001 | 6 | |
| 19 | 1995 | 2 | |
| 20 | 1994 | 36 |
About Akihiko Osaki
Akihiko Osaki is a scholar working on Cancer Research, Oncology and Hepatology, having authored 116 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (24 papers), Cancer Treatment and Pharmacology (23 papers), Estrogen and related hormone effects (13 papers), Breast Lesions and Carcinomas (13 papers), Liver Disease and Transplantation (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Medical Imaging Techniques and Applications (8 papers). The work is most often cited by research in Cancer Research (528 citations), Oncology (747 citations) and Radiology, Nuclear Medicine and Imaging (325 citations). Akihiko Osaki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Tetsuya Toge, Takashi Shigekawa, Toshiaki Saeki, Shigeto Ueda, Toshiaki Saeki, Ichiei Kuji, Kazuhiro Ikeda, Satoshi Inoue, Kuniko Horie‐Inoue and Tomohiko Yamane. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.